ArticleBiomedicines2025

Copeptin and Mid-Regional Proadrenomedullin Are Not Useful Biomarkers of Cardiometabolic Disease in Patients with Acromegaly-A Preliminary Study.

Martyna Strzelec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.